OrthoXel Marks First Clinical Use of Apex Tibial Nail

Following its receipt of FDA 510(k) clearance and CE Mark approval as announced in January 2018, OrthoXel's Apex Tibial Nail has now been implanted in the first clinical trial patient.

Apex uses controlled micromotion to stimulate callus formation in pursuit of reduced healing time. The nail offers a large range of locking options...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us